Issue link: https://beckershealthcare.uberflip.com/i/976338
52 GI/ENDOSCOPY aer identifying a significant unmet need in the field, Evoke Pharmas is focused on developing drugs to treat GI diseases. e company's lead product is Gimoti, a nasal spray used to relieve symptoms associated with gastroparesis. Evoke was founded by David Gonyer and Matthew D'Onofrio, who still oversee the company today. Exact Sciences Corp. (Madison, Wis.). Founded in 1995, Exact Sciences is committed to eradicating colorectal cancer. e company's flagship product, Cologuard, is the first noninvasive screening test for colorectal cancer. Cologuard analyzes both stool DNA and blood biomarkers at a 92 percent success rate. Led by Kevin Conroy, Exact Sciences has expanded rapidly since Cologuard's debut. e biopharmaceutical company is currently building a second headquarters in Madison, Wis., and is in the midst of developing other cancer-detecting tests, including a liquid biopsy-based test. Fujifilm Medical Systems USA (Stamford, Conn.). e company is the U.S.-based branch of international technology conglomer- ate Fujifilm. e U.S. division leads the company's endoscopy efforts. Fujifilm touts one of the largest-scope portfolios of the major GI companies, meeting a need in two key areas: GI endo- scopes and double balloon endoscopy. Fujifilm debuted its new video endoscopy system Eluxeo in October 2017. e company has also been active in the awareness space, partnering with Fight Colorectal Cancer in recognition of Colon Cancer Aware- ness Month. gMed, a Modernizing Medicine Co. (Weston, Fla.) Founded in 1997 and acquired by Modernizing Medicine in 2015, gMed pro- vides the GI industry with a fully integrated platform consisting of an EHR system, Endoscopy Report Writer, practice manage- ment solution, patient portal, data analytics and revenue cycle management services. Modernizing Medicine hired Dr. Arnold G. Levy, a renowned gastroenterologist with over 40 years of clinical experience, as a strategic advisor and announced its deci- sion to substantially increase the company's investment in the gGastro platform. Interscope (Whitinsville, Mass.). e proprietors of the EndoRo- tor — a single interventional tool for mucosal resection — In- terscope is led by Jeffery Ryan Jr., the company's co-founder, president and CEO. He's assisted by Ramon Franco Jr., MD, the company's co-founder and chief scientific officer. Interscope was founded to develop novel interventional endoscopic techniques that promote outpatient surgery. Johnson & Johnson (New Brunswick, N.J.). With Chairman and CEO Alex Gorsky at the helm, Johnson & Johnson is a provider of medical devices, pharmaceutical products and consumer healthcare products. Johnson & Johnson encompasses Ethicon's energy, endocutters and biosurgery businesses, as well as the global orthopedics business DePuy Synthes. e company develops pharmaceutical treatments in other areas, including immunology, cardiovascular health, infectious diseases and vaccines, oncology, and pulmonary hypertension. Motus GI (Fort Lauderdale, Fla.). Motus GI is a medical technol- ogy company focused on improving endoscopy outcomes and experiences. Its flagship product is the Pure-Vu System, an FDA- approved device for cleaning a poorly prepped colon to gain a clear view of the colon mucosa during a colonoscopy procedure. CEO Mark Pomeranz joined Motus GI in 2014. Olympus Corp. of the Americas (Center Valley, Pa.). Nacho The TIF® procedure with the EsophyX® device is an incisionless procedure to control typical and atypical GERD symptoms. In the past 10 years, 4 randomized controlled trials and more than 80 peer-reviewed papers have documented consistent outcomes in over 1,300 unique study patients. So help your patients today with the TIF® procedure. And help Jacob regain what was lost. www.EndoGastricSolutions.com The TIF® procedure is designed to treat GERD symptoms with the EsophyX® technology – a cleared device. Results may vary; visit GERDHelp. com for clinical data. EndoGastric Solutions, Inc. is the manufacturer and owner of these trademarks: TIF, EsophyX and SerosaFuse. ©2018 All rights reserved. NP02456-01D GERD has taken a lot from your patients. Help Jacob re-join the adventure. Jacob GERD sufferer for 10 years